AbbVie Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (206)

Latest Posts

About This Stock More About This Stock
Healthcare And Biotech Investing 101: What You Need To Know.
Article By: Rod Raynovich
Monday, May 13, 2024 4:44 AM EDT
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of demographics and government funding through Medicare.
In this article: LLY, MRK, TMO, UNH, FSMEX, REGN, XLV, ABBV
Read
Tuesday Talk: Big-Tech Under Attack
Article By: David Marshall
Tuesday, March 26, 2024 5:20 AM EDT
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.
In this article: LLY, IBB, BIIB, XBI, XLV, CERE, ABBV Also: ADM, MU, TSLA
Read
AbbVie Posts Less-Than-Healthy Financial Results For 2023
Article By: Invezz
Friday, February 2, 2024 8:30 AM EDT
Pharmaceuticals company AbbVie reported its Q4 and full year financial results for 2023.
In this article: ABBV
Read
3 Stocks Enjoying Favorable Analyst Coverage
Article By: Zacks Investment Research
Monday, January 29, 2024 10:40 PM EDT
We see daily analyst upgrades and downgrades, coming with price targets. They can be helpful tools for investors, providing a more structured plan and helping to inject positivity surrounding future performance
In this article: HSY, DLTR, ABBV
Read
ABBV: This Top Biotech Just Went On A Buying Spree
Article By: Tony Daltorio
Thursday, January 25, 2024 7:00 AM EDT
AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel).
In this article: ABBV Also: IMGN, AMGN, CERE, KRTX
Read

Latest Tweets for $ABBV

No tweets yet!

PARTNER HEADLINES

$ABBV

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/11/2020 4:12:58 AM

Just a hunch. The healthcare industry is highly regulated and Dems generally favor more regulation, making it more difficult for drugmakers to secure the necessary regulatory approvals to market new products. Regulatory changes could drastically alter a healthcare stock’s growth prospects, for instance. But I reckon I'll not sell $ABBV after holding during all the long downward spiral.

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/10/2020 2:44:59 AM

Seems health stocks should do well but a #Biden presidency will not favor this sector. $ABBV $PFE

Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
Beating Buffett 7/11/2019 1:00:14 PM

How much debt does $ABBV have?

AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
Dan Richards 6/25/2019 11:19:59 PM

$ABBV certainly sounds like a great buy.

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 6 of 6 comments